"The acquisition process has run very smoothly," said S. Parikh Mars, CEO of Progressive Care. "We believe that acquisition will be conducted in stages similar to that of PharmCo 1002, starting in few weeks and completing in the second quarter of 2019. This structure ensures that we will meet all regulatory requirements of the relevant governing agencies. We are excited to continue in the process and make sure that the closing and transition are executed properly."